A Multi-Center, Randomized, Double-blind, Placebo-controlled Dose-ranging Study Evaluating Efficacy and Safety of SHR-1314 in Subjects with Moderate-to-Severe Plaque Psoriasis-MedSci.cn

A Multi-Center, Randomized, Double-blind, Placebo-controlled Dose-ranging Study Evaluating Efficacy and Safety of SHR-1314 in Subjects with Moderate-to-Severe Plaque Psoriasis

Zhang, CL; Yan, KX; Diao, QC; Guo, Q; Jin, HZ; Yang, S; Chen, X; Lei, TC; Wu, JH; Yu, H; Zheng, M; Gao, XH; Sinclair, R; Alonso, D; Zhu, Y; Xu, Q; Xu, JH

ARTHRITIS & RHEUMATOLOGY, 2020; 72 ():

科室
- - 订阅+
  - 更多科室
工具
服务

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

A Multi-Center, Randomized, Double-blind, Placebo-controlled Dose-ranging Study Evaluating Efficacy and Safety of SHR-1314 in Subjects with Moderate-to-Severe Plaque Psoriasis

科室

工具

服务